Susquehanna Fundamental Investments LLC Buys Shares of 33,975 DocuSign, Inc. (NASDAQ:DOCU)

Susquehanna Fundamental Investments LLC bought a new position in shares of DocuSign, Inc. (NASDAQ:DOCU) in the second quarter, Holdings Channel.com reports. The fund bought 33,975 shares of the company’s stock, valued at approximately $1,818,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Dakota Wealth Management increased its stake in shares of DocuSign by 0.8% in the 2nd quarter. Dakota Wealth Management now owns 23,022 shares of the company’s stock worth $1,232,000 after acquiring an additional 181 shares during the last quarter. New York State Teachers Retirement System increased its position in DocuSign by 1.0% during the first quarter. New York State Teachers Retirement System now owns 18,469 shares of the company’s stock worth $1,100,000 after purchasing an additional 187 shares during the last quarter. Elo Mutual Pension Insurance Co raised its stake in DocuSign by 1.1% during the second quarter. Elo Mutual Pension Insurance Co now owns 18,848 shares of the company’s stock worth $1,008,000 after purchasing an additional 214 shares during the period. Motley Fool Asset Management LLC boosted its holdings in DocuSign by 6.0% in the 1st quarter. Motley Fool Asset Management LLC now owns 3,960 shares of the company’s stock valued at $236,000 after purchasing an additional 224 shares during the last quarter. Finally, Optimist Retirement Group LLC grew its stake in shares of DocuSign by 5.6% in the 2nd quarter. Optimist Retirement Group LLC now owns 4,255 shares of the company’s stock valued at $228,000 after buying an additional 227 shares during the period. 77.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at DocuSign

In other DocuSign news, Director Teresa Briggs sold 534 shares of the business’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $56.56, for a total value of $30,203.04. Following the completion of the sale, the director now owns 7,202 shares in the company, valued at $407,345.12. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $56.56, for a total transaction of $30,203.04. Following the transaction, the director now owns 7,202 shares of the company’s stock, valued at $407,345.12. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Stephen Shute sold 35,300 shares of the company’s stock in a transaction that occurred on Tuesday, July 9th. The shares were sold at an average price of $52.87, for a total value of $1,866,311.00. The disclosure for this sale can be found here. Insiders have sold a total of 438,154 shares of company stock worth $23,351,788 over the last ninety days. Corporate insiders own 1.66% of the company’s stock.

Analyst Upgrades and Downgrades

DOCU has been the topic of a number of recent analyst reports. Citigroup upped their price objective on DocuSign from $86.00 to $87.00 and gave the company a “buy” rating in a report on Friday, September 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday, September 6th. Bank of America increased their target price on shares of DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Morgan Stanley reduced their price target on shares of DocuSign from $65.00 to $62.00 and set an “equal weight” rating on the stock in a research note on Friday, June 7th. Finally, Robert W. Baird increased their price objective on shares of DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $63.40.

DocuSign Price Performance

Shares of NASDAQ DOCU opened at $61.42 on Wednesday. DocuSign, Inc. has a 1-year low of $38.11 and a 1-year high of $64.76. The company has a market cap of $12.57 billion, a price-to-earnings ratio of 118.12, a price-to-earnings-growth ratio of 6.37 and a beta of 0.93. The stock’s 50-day moving average is $56.52 and its two-hundred day moving average is $56.41.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, September 5th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The company had revenue of $736.03 million during the quarter, compared to analysts’ expectations of $727.20 million. During the same quarter in the previous year, the business posted $0.09 EPS. The firm’s revenue was up 7.0% on a year-over-year basis. Equities research analysts anticipate that DocuSign, Inc. will post 0.99 earnings per share for the current fiscal year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.